Simulations Plus, Inc. (NASDAQ:SLP) Stock Has Average Price Target of $17.25 According to Brokerages

Shares of Simulations Plus, Inc. (NASDAQ:SLP) have received a consensus recommendation of “Reduce” from the eight analysts that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation and seven have given a hold recommendation to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $17.25.

Several equities analysts have commented on the company. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Simulations Plus in a research report on Tuesday, October 6th. BTIG Research reiterated a “neutral” rating on shares of Simulations Plus in a research note on Wednesday, October 7th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC raised its position in shares of Simulations Plus by 242.6% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,384 shares of the technology company’s stock worth $26,000 after acquiring an additional 980 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new stake in shares of Simulations Plus during the 2nd quarter worth $26,000. GAMMA Investing LLC lifted its stake in shares of Simulations Plus by 26.0% during the 2nd quarter. GAMMA Investing LLC now owns 2,831 shares of the technology company’s stock worth $52,000 after purchasing an additional 585 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its position in Simulations Plus by 343.0% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,983 shares of the technology company’s stock valued at $73,000 after purchasing an additional 3,084 shares in the last quarter. Finally, Longfellow Investment Management Co. LLC bought a new stake in Simulations Plus during the second quarter valued at about $77,000. 78.08% of the stock is currently owned by institutional investors.

Simulations Plus Price Performance

Shares of NASDAQ SLP opened at $18.50 on Tuesday. The business’s 50 day moving average is $18.44 and its two-hundred day moving average is $17.18. Simulations Plus has a 1-year low of $11.09 and a 1-year high of $21.01. The stock has a market capitalization of $374.16 million, a P/E ratio of 46.25 and a beta of 1.31.

About Simulations Plus

Simulations Plus, Inc develops software and provides consulting services for pharmaceutical research and development. Its technology helps scientists model how drugs are absorbed, distributed, metabolized and excreted in the body, supporting decisions throughout the drug-development process.

The company’s product portfolio includes GastroPlus, a physiologically based pharmacokinetic modeling platform; ADMET Predictor, which supports the prediction of drug absorption, distribution, metabolism, excretion and toxicity properties; and DILIsym, a platform designed to evaluate the risk of drug-induced liver injury.